Treatment tolerance, tumor response, and clinical toxicity associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small cell lung cancer (NSCLC) in Chinese patients.

Abstract

e19138 Background: Previously reported superior tumor response associated with platinum/pemetrexed in the first-line setting for for advanced non-squamous NSCLC has not been confirmed in real-world...